Search research articles
Contact Us
Filters
Showing results (161-170 of 467) with videos related to
Page
of 47
Sort By:
Medicines (Basel, Switzerland)
|
February 20, 2026
Significant Impact of Previous Major Cardiovascular Events (MACEs) and Viremia on Risk of New MACEs in People Living with HIV on Antiretroviral Therapy
Caterina Candela, Alessia Siribelli, Tommaso Clemente, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
May 30, 2026
Impact of doxycycline post-exposure prophylaxis on Neisseria gonorrhoeae antimicrobial resistance to doxycycline and ceftriaxone in Milan, Italy
Angelo Roberto Raccagni, Chiara Sagramoso, Nicolò Capra, et al.
Materials (Basel, Switzerland)
|
August 5, 2017
Microwave-Assisted Drying for the Conservation of Honeybee Pollen
Angelo Canale, Giovanni Benelli, Antonella Castagna, et al.
Biomed Research International
|
April 6, 2018
Eosinophils from Physiology to Disease: A Comprehensive Review
Giuseppe A Ramirez, Mona-Rita Yacoub, Marco Ripa, et al.
Journal of the International AIDS Society
|
November 14, 2014
Predictors of lack of serological response to syphilis treatment in HIV-infected subjects
Vincenzo Spagnuolo, Andrea Poli, Laura Galli, et al.
Scientific Reports
|
April 4, 2023
Profiling Covid-19 patients with respect to level of severity: an integrated statistical approach
Federica Cugnata, Maria Giovanna Scarale, Rebecca De Lorenzo, et al.
The New Microbiologica
|
July 18, 2024
Non-O1 and non-O139 Vibrio cholerae Septicemia and Cellulitis: a Case Report
Marcella Negri, Floriana Gona, Chiara Tassan Din, et al.
BMC Infectious Diseases
|
November 18, 2017
Durability of switch regimens based on rilpivirine or on integrase inhibitors, both in association with tenofovir and emtricitabine, in HIV-infected, virologically suppressed patients
Nicola Gianotti, Andrea Poli, Silvia Nozza, et al.
The New Microbiologica
|
August 6, 2013
Boosted or unboosted atazanavir as a simplification of lopinavir/ritonavir-containing regimens
Antonella Castagna, Laura Galli, Nicola Gianotti, et al.
BMC Infectious Diseases
|
January 8, 2017
Associations of statins and antiretroviral drugs with the onset of type 2 diabetes among HIV-1-infected patients
Vincenzo Spagnuolo, Laura Galli, Andrea Poli, et al.
Page
of 47
Search research articles
Search
Showing results (161-170 of 467) with videos related to
Sort By:
Page
of 47
Medicines (Basel, Switzerland)
|
February 20, 2026
Significant Impact of Previous Major Cardiovascular Events (MACEs) and Viremia on Risk of New MACEs in People Living with HIV on Antiretroviral Therapy
Caterina Candela, Alessia Siribelli, Tommaso Clemente, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
May 30, 2026
Impact of doxycycline post-exposure prophylaxis on Neisseria gonorrhoeae antimicrobial resistance to doxycycline and ceftriaxone in Milan, Italy
Angelo Roberto Raccagni, Chiara Sagramoso, Nicolò Capra, et al.
Materials (Basel, Switzerland)
|
August 5, 2017
Microwave-Assisted Drying for the Conservation of Honeybee Pollen
Angelo Canale, Giovanni Benelli, Antonella Castagna, et al.
Biomed Research International
|
April 6, 2018
Eosinophils from Physiology to Disease: A Comprehensive Review
Giuseppe A Ramirez, Mona-Rita Yacoub, Marco Ripa, et al.
Journal of the International AIDS Society
|
November 14, 2014
Predictors of lack of serological response to syphilis treatment in HIV-infected subjects
Vincenzo Spagnuolo, Andrea Poli, Laura Galli, et al.
Scientific Reports
|
April 4, 2023
Profiling Covid-19 patients with respect to level of severity: an integrated statistical approach
Federica Cugnata, Maria Giovanna Scarale, Rebecca De Lorenzo, et al.
The New Microbiologica
|
July 18, 2024
Non-O1 and non-O139 Vibrio cholerae Septicemia and Cellulitis: a Case Report
Marcella Negri, Floriana Gona, Chiara Tassan Din, et al.
BMC Infectious Diseases
|
November 18, 2017
Durability of switch regimens based on rilpivirine or on integrase inhibitors, both in association with tenofovir and emtricitabine, in HIV-infected, virologically suppressed patients
Nicola Gianotti, Andrea Poli, Silvia Nozza, et al.
The New Microbiologica
|
August 6, 2013
Boosted or unboosted atazanavir as a simplification of lopinavir/ritonavir-containing regimens
Antonella Castagna, Laura Galli, Nicola Gianotti, et al.
BMC Infectious Diseases
|
January 8, 2017
Associations of statins and antiretroviral drugs with the onset of type 2 diabetes among HIV-1-infected patients
Vincenzo Spagnuolo, Laura Galli, Andrea Poli, et al.
Page
of 47